DC vaccine
Commercial- Indications
- Nasopharyngeal cancer, Lung cancer, Colorectal cancer, Pancreatic cancer, Liver cancer
Company intelligence / Profile preview
Vectorite provides contract manufacturing for immune cell therapies such as dendritic cell vaccines and NK-cell preparations. The company also offers cryopreservation services and has developed or licensed key immunotherapy technologies. Products are mainly sold domestically in Taiwan with a focus on cancer treatment applications. No published pivotal clinical trial results were found; the company’s main business is service provision rather than direct product commercialization.[1][2]
1 more asset in the full pipeline.
Request access →Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Vectorite Biomedical Inc..